Want to see PULM full AI Analyst Report?
Pulmatrix (PULM) Stock Statistics & Valuation Metrics
Total Valuation
Pulmatrix has a market cap or net worth of $5.11M. The enterprise value is $4.31M.
- Market Cap
- $5.11M
- Enterprise Value
- $4.31M
Share Statistics
Pulmatrix has 3,652,285 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 3,652,285
- Owned by Insiders
- ―
- Owned by Institutions
- 3.13%
Financial Efficiency
Pulmatrix’s return on equity (ROE) is -1.35 and return on invested capital (ROIC) is -135.67%.
- Return on Equity (ROE)
- -1.35
- Return on Assets (ROA)
- -1.25
- Return on Invested Capital (ROIC)
- -135.67%
- Return on Capital Employed (ROCE)
- -1.36
- Revenue Per Employee
- 0
- Profits Per Employee
- -2.58M
- Employee Count
- 2
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Pulmatrix is -1.27. Pulmatrix’s PEG ratio is -0.02.
- PE Ratio
- -1.27
- PS Ratio
- 0.00
- PB Ratio
- 2.00
- Price to FCF
- -1.31
- Price to Operating Cash Flow
- -1.31
- PEG Ratio
- -0.02
Income Statement
In the last 12 months, Pulmatrix had revenue of 0 and earned -5.16M in profits. Earnings per share was -1.41.
- Revenue
- 0
- Gross Profit
- -38.00K
- Operating Income
- -5.17M
- Pretax Income
- -5.16M
- Net Income
- -5.16M
- EBITDA
- -5.16M
- Earnings Per Share (EPS)
- -1.41
Cash Flow
In the last 12 months, operating cash flow was -3.91M and capital expenditures 0, giving a free cash flow of -3.91M billion.
- Operating Cash Flow
- -3.91M
- Free Cash Flow
- -3.91M
- Free Cash Flow per Share
- -1.07
Dividends & Yields
Pulmatrix pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -76.47%
- Earnings Yield
- -78.48%
Stock Price Statistics
- Beta
- -0.23
- 52-Week Price Change
- -71.66%
- 50-Day Moving Average
- 1.49
- 200-Day Moving Average
- 1.70
- Relative Strength Index (RSI)
- 44.90
- Average Volume (3m)
- 27.12K
Important Dates
Pulmatrix upcoming earnings date is Nov 05, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 13, 2026
- Next Earnings Date
- Nov 05, 2026
- Ex-Dividend Date
- ―
Financial Position
Pulmatrix as a current ratio of 12.55, with Debt / Equity ratio of 0.00%
- Current Ratio
- 12.55
- Quick Ratio
- 12.55
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.79
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Pulmatrix has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Pulmatrix EV to EBITDA ratio is -0.73, with an EV/FCF ratio of -0.75.
- EV to Sales
- 0.00
- EV to EBITDA
- -0.73
- EV to Free Cash Flow
- -0.75
- EV to Operating Cash Flow
- -0.75
Balance Sheet
Pulmatrix has $2.17M in cash and marketable securities with $0.00 in debt, giving a net cash position of $2.17M billion.
- Cash & Marketable Securities
- $2.17M
- Total Debt
- $0.00
- Net Cash
- $2.17M
- Net Cash Per Share
- $0.59
- Tangible Book Value Per Share
- $0.70
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Pulmatrix is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -100.00%
- EPS Growth Forecast
- 49.19%
Scores
- Smart Score
- ―
- AI Score
- 45